APA (7th ed.) Citation

Shenderov, E., Mallesara, G., Wysocki, P., Xu, W., Ramlau, R., Weickhardt, A., . . . Lugowska, I. (2021). 620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion. Annals of Oncology, 32, S657. https://doi.org/10.1016/j.annonc.2021.08.1133

Chicago Style (17th ed.) Citation

Shenderov, E., et al. "620P MGC018, an Anti-B7-H3 Antibody-drug Conjugate (ADC), in Patients with Advanced Solid Tumors: Preliminary Results of Phase I Cohort Expansion." Annals of Oncology 32 (2021): S657. https://doi.org/10.1016/j.annonc.2021.08.1133.

MLA (9th ed.) Citation

Shenderov, E., et al. "620P MGC018, an Anti-B7-H3 Antibody-drug Conjugate (ADC), in Patients with Advanced Solid Tumors: Preliminary Results of Phase I Cohort Expansion." Annals of Oncology, vol. 32, 2021, p. S657, https://doi.org/10.1016/j.annonc.2021.08.1133.